|
SEGMENT INFORMATION (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
segment
|
Sep. 30, 2012
|
|
| Segment information | ||||
| Number of reportable segments | 3 | |||
| Segment information | ||||
| Total net sales | $ 1,197.5 | $ 813.5 | $ 3,531.5 | $ 2,541.1 |
| Long-lived asset impairment charges (recoveries), net | 25.8 | 28.4 | (0.8) | |
| Transaction related costs and other, net | 14.8 | 14.8 | 33.7 | 27.2 |
| Gain on sale of assets | (1.9) | (19.3) | ||
| Operating income (loss) | 78.1 | 73.9 | 273.9 | 170.5 |
| Depreciation and amortization | 56.8 | 23.0 | 157.1 | 68.0 |
| Capital expenditures | 52.9 | 15.1 | 108.5 | 55.8 |
|
Operating segments
|
||||
| Segment information | ||||
| Total net sales | 1,197.5 | 813.5 | 3,531.5 | 2,541.1 |
|
Chlorovinyls
|
||||
| Segment information | ||||
| Total net sales | 750.0 | 329.1 | 2,166.3 | 998.5 |
| Transaction related costs and other, net | 1.5 | 1.3 | 4.7 | 1.3 |
| Gain on sale of assets | (1.9) | (19.3) | ||
| Operating income (loss) | 101.6 | 73.8 | 311.0 | 160.2 |
| Depreciation and amortization | 45.7 | 11.5 | 124.7 | 34.0 |
| Capital expenditures | 36.0 | 7.9 | 74.9 | 32.1 |
|
Chlorovinyls | Operating segments
|
||||
| Segment information | ||||
| Total net sales | 811.8 | 384.8 | 2,351.1 | 1,193.2 |
|
Chlorovinyls | Intersegment elimination
|
||||
| Segment information | ||||
| Total net sales | 61.8 | 55.7 | 184.8 | 194.7 |
|
Building Products
|
||||
| Segment information | ||||
| Number of primary product groups | 2 | |||
| Segment information | ||||
| Total net sales | 253.4 | 246.2 | 660.0 | 685.8 |
| Long-lived asset impairment charges (recoveries), net | 25.8 | 28.4 | (0.8) | |
| Transaction related costs and other, net | 2.9 | 0.4 | 2.7 | 0.6 |
| Operating income (loss) | (6.7) | 14.7 | (0.9) | 23.7 |
| Depreciation and amortization | 9.1 | 9.9 | 26.5 | 29.4 |
| Capital expenditures | 11.0 | 4.7 | 24.1 | 15.1 |
|
Building Products | Operating segments
|
||||
| Segment information | ||||
| Total net sales | 253.4 | 246.3 | 660.0 | 686.2 |
|
Building Products | Intersegment elimination
|
||||
| Segment information | ||||
| Total net sales | 0.1 | 0.4 | ||
|
Aromatics
|
||||
| Segment information | ||||
| Total net sales | 194.1 | 238.2 | 705.2 | 856.8 |
| Operating income (loss) | 5.2 | 11.1 | 22.5 | 46.2 |
| Depreciation and amortization | 0.3 | 0.3 | 0.9 | 1.1 |
| Capital expenditures | 2.0 | 0.8 | 3.0 | 1.8 |
|
Aromatics | Operating segments
|
||||
| Segment information | ||||
| Total net sales | 194.1 | 238.2 | 705.2 | 856.8 |
|
Eliminations, Unallocated and Other
|
||||
| Segment information | ||||
| Transaction related costs and other, net | 10.4 | 13.1 | 26.3 | 25.3 |
| Operating income (loss) | (22.0) | (25.7) | (58.7) | (59.6) |
| Depreciation and amortization | 1.7 | 1.3 | 5.0 | 3.5 |
| Capital expenditures | 3.9 | 1.7 | 6.5 | 6.8 |
|
Eliminations, Unallocated and Other | Operating segments
|
||||
| Segment information | ||||
| Total net sales | (61.8) | (55.8) | (184.8) | (195.1) |
|
Eliminations, Unallocated and Other | Intersegment elimination
|
||||
| Segment information | ||||
| Total net sales | $ (61.8) | $ (55.8) | $ (184.8) | $ (195.1) |